BCU-FTS-57591 Blood Transfusion Managed Service

The Betsi Cadwaladr University Health Board is undertaking a public procurement process in North Wales for a Managed Service Provider to deliver bespoke In Vitro Diagnostics support for Transfusion Services. The procurement is at the planning stage, with a planned contract period from 1 April 2028 to 31 March 2036, renewable until 2043. The opportunity is categorised under pathology and blood analysis within the services sector, with a focus on locations including regions UKL23, UKL13, and UKL12 in the United Kingdom.

The contracting process is conducted under the legal basis of the UK Public General Act 2023/54 and is managed by the NHS Wales Shared Services Partnership on behalf of the Health Board. This tender offers significant growth potential for businesses specialising in laboratory services and pathology, particularly those experienced in providing transfusion support across multiple sites with continuous 24/7 operation capabilities. Companies with established credentials in managing similar services, compliance with regulatory standards like the MHRA, and a proven record of operating under unified accreditation frameworks are well-suited to compete for this contract.

Involvement in this procurement process could solidify a provider's presence in the healthcare sector in North Wales, fostering opportunities for long-term collaboration and expansion.